Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment
Authors:
Open Access
- 26 January 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-11
Abstract
We studied whether in patients with COPD the use of metformin for diabetes treatment was linked to a pattern of lung function decline consistent with the hypothesis of anti-aging effects of metformin. Patients of GOLD grades 1–4 of the COSYCONET cohort with follow-up data of up to 4.5 y were included. The annual decline in lung function (FEV1, FVC) and CO diffusing capacity (KCO, TLCO) in %predicted at baseline was evaluated for associations with age, sex, BMI, pack-years, smoking status, baseline lung function, exacerbation risk, respiratory symptoms, cardiac disease, as well as metformin-containing therapy compared to patients without diabetes and metformin. Among 2741 patients, 1541 (mean age 64.4 y, 601 female) fulfilled the inclusion criteria. In the group with metformin treatment vs. non-diabetes the mean annual decline in KCO and TLCO was significantly lower (0.2 vs 2.3, 0.8 vs. 2.8%predicted, respectively; p < 0.05 each), but not the decline of FEV1 and FVC. These results were confirmed using multiple regression and propensity score analyses. Our findings demonstrate an association between the annual decline of lung diffusing capacity and the intake of metformin in patients with COPD consistent with the hypothesis of anti-aging effects of metformin as reflected in a surrogate marker of emphysema.Keywords
Funding Information
- Ludwig-Maximilians-Universität München
This publication has 52 references indexed in Scilit:
- Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysemaTranslational Research, 2013
- Clusters of Comorbidities Based on Validated Objective Measurements and Systemic Inflammation in Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Short telomere length, lung function and chronic obstructive pulmonary disease in 46 396 individualsThorax, 2012
- COPD/Emphysema: The Vascular StoryPulmonary Circulation, 2011
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy stateJournal of Clinical Investigation, 2010
- The Aging Lung and Chronic Obstructive Pulmonary Disease: Similarity and DifferenceProceedings of the American Thoracic Society, 2009
- Aging and induced senescence as factors in the pathogenesis of lung emphysemaRespiratory Medicine, 2008
- Mechanisms of cigarette smoke-induced COPD: insights from animal modelsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Alveolar Cell Senescence in Patients with Pulmonary EmphysemaAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Increased p21CIP1/WAF1 and B Cell Lymphoma Leukemia-xL Expression and Reduced Apoptosis in Alveolar Macrophages from SmokersAmerican Journal of Respiratory and Critical Care Medicine, 2002